Greater Boston is home to more than one thousand biotechnology companies, from small startups to large pharmaceutical giants, making major developments to how genetic diseases are cured and cancers are treated.
Massachusetts based companies have developed therapies that treat more than 265 million patients in the United states and 2 billion patients around the world. An ecosystem spurred by the collaboration between academia, industries and government, these collaborations led to the birth of the biotechnology industry and has made Massachusetts home to the highest concentration of biotech companies in the world.
In the last decade, Massachusetts has added 11 million square feet of lab space and just last year alone, the companies in the state received $3 billion in venture capital investment, these statistics cannot be replicated anywhere in the world.